CHF: SNB is likely near the end of its easing cycle – UBS
Swiss National Bank (SNB) seems to be near the end of its easing cycle, and the Swiss Franc (CHF) should appreciate against both the US Dollar (USD) and the Euro (EUR), UBS FX analysts note.
USD/CHF to fall back toward 0.87
“We believe the Swiss National Bank (SNB) policy rate is now closer to its terminal value after two cuts this year amid a decrease in underlying inflationary pressure, with one final cut likely in September.”
“This means the CHF should appreciate against both the US dollar and EUR over the next 12 months as the Fed and the European Central Bank (ECB) ramp up monetary policy easing.”
“The narrowing rate differential between the US and Switzerland should allow USD/CHF to fall back toward 0.87, from around 0.896 at present, while political uncertainty and fiscal consolidation in Europe should support safe-haven flows to the franc.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.